Are GLP-1s Safe for Seniors
One long-term trial found that taking 800mg daily for four years improved CRP levels and glucose control.36 1,2001,800mg/day Higher doses in this range have been explored in short-term studies, particularly for more advanced cases of neuropathy or obesity
There were no changes in training or dietary protocols other than the administration of glutathione intravenously
Furthermore, the administration of exogenous GLP-1 resulted in elevated calcitonin expression in the thyroids of normal (wild-type) mice
Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care. Journal of Personalized Medicine , vol
For instance, semaglutide has shown promising benefits in reducing the risk of cardiovascular events and reducing symptoms of a difficult-to-treat type of heart failure